Molly Torok
The Ohio State University Wexner Medical Center(US)The Ohio State University(US)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Epigenetics and DNA Methylation, Autophagy in Disease and Therapy, Pancreatitis Pathology and Treatment, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → CD200 promotes immunosuppression in the pancreatic tumor microenvironment(2020)96 cited
- → Regulation of cellular immunity by activating transcription factor 4(2020)41 cited
- → Tomatidine targets ATF4-dependent signaling and induces ferroptosis to limit pancreatic cancer progression(2023)33 cited
- → The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer(2022)9 cited
- → Soy-tomato enriched diet reduces inflammation and disease severity in a pre-clinical model of chronic pancreatitis(2020)7 cited
- → CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival(2024)7 cited
- → Systemic Neutrophil Gelatinase-Associated Lipocalin Alterations in Chronic Pancreatitis: A Multicenter, Cross-Sectional Study(2024)3 cited
- → 678 The neonatal Fc receptor is elevated in monocyte-derived immune cells in pancreatic cancer(2021)1 cited
- → Abstract B097: Tomatidine inhibits ATF4 activity and induces ferroptosis to limit pancreatic cancer progression(2024)
- → Abstract B077: Tomatidine targets ATF4-dependent signaling to limit pancreatic cancer in the tumor microenvironment(2022)